Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- CTRADIndependent statistical analysis of Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CTREPHIndependent statistical analysis of Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CTS-1027 in Interferon-Naive Hepatitis C Patients: Complete Statistical AnalysisIndependent statistical analysis of CTS-1027 in Interferon-Naive Hepatitis C Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00925990).
- CTSI Pilot: Improving Adherence to Diabetic Diet: Complete Statistical AnalysisIndependent statistical analysis of CTSI Pilot: Improving Adherence to Diabetic Diet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04051008).
- CTSI-PLACEIndependent statistical analysis of A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CU-Q2oLIndependent statistical analysis of The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Culturally Tailored HPV Psychoeducational Multimedia Intervention: Complete Statistical AnalysisIndependent statistical analysis of Culturally Tailored HPV Psychoeducational Multimedia Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06098690).
- CURBIndependent statistical analysis of Cocaine Use Reduction With Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01402492).
- Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Curing Atrial Fibrillation in Heart Failure: Complete Statistical AnalysisIndependent statistical analysis of Curing Atrial Fibrillation in Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00292162).
- Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools: Complete Statistical AnalysisIndependent statistical analysis of Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients: Complete Statistical AnalysisIndependent statistical analysis of Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02544503).
- CUTEXIndependent statistical analysis of Cold Urticaria Treatment With Xolair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580592).
- CV_WIZARDIndependent statistical analysis of CV Wizard: Does a Clinical Decision Support Tool Improve CVD Risk Factor Control in Safety Net Clinics?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CVT-ISR First in Human Trial for Coronary In-Stent Restenosis: Complete Statistical AnalysisIndependent statistical analysis of CVT-ISR First in Human Trial for Coronary In-Stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05731700).
- CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry: Complete Statistical AnalysisIndependent statistical analysis of CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels: Complete Statistical AnalysisIndependent statistical analysis of Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01678313).
- Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis: Complete Statistical AnalysisIndependent statistical analysis of Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001213).
- Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery: Complete Statistical AnalysisIndependent statistical analysis of Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04302545).
- CYTOFLOCIndependent statistical analysis of Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03529669).
- D Mannose in Recurrent Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of D Mannose in Recurrent Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01808755).
- D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01157429).
- D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00864123).
- D-Cycloserine Enhancement of Exposure in Social Phobia: Complete Statistical AnalysisIndependent statistical analysis of D-Cycloserine Enhancement of Exposure in Social Phobia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00633984).
- D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism: Complete Statistical AnalysisIndependent statistical analysis of D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- D-LUCSIndependent statistical analysis of Combined Pharmacotherapy for Cannabis Dependency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01020019).
- D-MAPIndependent statistical analysis of Shared Decision Making Aid for Prosthetic Design: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04536025).
- D-serine Augmentation of Neuroplasticity: Complete Statistical AnalysisIndependent statistical analysis of D-serine Augmentation of Neuroplasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03711500).
- D&DIndependent statistical analysis of Dyslipidemia and Diabetic Retinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03403283).
- D2P3Independent statistical analysis of Effect of Spinal Manipulation on Sensorimotor Functions in Back Pain Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites: Complete Statistical AnalysisIndependent statistical analysis of Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites: primary endpoint results, effect estimate with confidence interval,…
- DACABIndependent statistical analysis of Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201771).
- Dacarbazine and Carmustine in Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Dacarbazine and Carmustine in Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01692691).
- Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance: Complete Statistical AnalysisIndependent statistical analysis of Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung: Complete Statistical AnalysisIndependent statistical analysis of Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DAHHS-2Independent statistical analysis of Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dailies Total 1 Sphere Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Dailies Total 1 Sphere Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05239494).
- DAILIES TOTAL1® Lens Centration in a Japanese Population: Complete Statistical AnalysisIndependent statistical analysis of DAILIES TOTAL1® Lens Centration in a Japanese Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02252133).
- Daily Disposable Comparison Study: Complete Statistical AnalysisIndependent statistical analysis of Daily Disposable Comparison Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02094677).
- Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV: Complete Statistical AnalysisIndependent statistical analysis of Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Daily Living Skills Intervention for 9th and 10th Graders With Autism Spectrum Disorders: Complete Statistical AnalysisIndependent statistical analysis of Daily Living Skills Intervention for 9th and 10th Graders With Autism Spectrum Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Daily Living Skills Intervention for Adolescents With Autism Spectrum Disorder: Complete Statistical AnalysisIndependent statistical analysis of Daily Living Skills Intervention for Adolescents With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03984487).
- Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02048722).